12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive–Compulsive Disorder
Paul Grant(National Institute of Mental Health), Susan E. Swedo(National Institute of Mental Health), Lorraine Lougee(Unknown), Lisa Joseph, Cristan Farmer(The Ohio State University), Carlos A. Zarate(National Institute of Mental Health), David A. Luckenbaugh(National Institutes of Health)
Cited by 78
Related Papers
Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases
|American Journal of Psychiatry|1998|1.5k
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser <i>v.</i> mood stabiliser alone
|The British Journal of Psychiatry|2004|328
A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections
|Biological Psychiatry|1999|252
Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders
|Biological Psychiatry|2005|241